# Assessing the Safety and Tolerability of a Single IV Dose of AZD9742 in Healthy Elderly Male and Female Subjects

> **NCT01154621** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 12 (actual)

## Conditions studied

- Tolerability
- Healthy
- Elderly

## Interventions

- **DRUG:** AZD9742
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01154621
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2010-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01154621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01154621, "Assessing the Safety and Tolerability of a Single IV Dose of AZD9742 in Healthy Elderly Male and Female Subjects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01154621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*